Karyopharm Therapeutics (KPTI) Total Liabilities (2012 - 2026)
Karyopharm Therapeutics' Total Liabilities came in at $441.49 million for Q2 2026, up 28.4% from $343.81 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Total Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Total Liabilities was $401.34 million, up 14.5% from FY2024.
- Total Liabilities carries a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
- Going back by year, Total Liabilities was $350.44 million in FY2024 (-7.0%), $376.64 million in FY2023 (+0.5%), $374.83 million in FY2022 (-2.6%) and $384.98 million in FY2021 (+46.7%).
- The Q2 2026 figure represents the highest quarterly Total Liabilities in data going back to Q4 2012.
- Year-over-year, Total Liabilities increased in three of the last seven quarters, with growth averaging 3.4%.
- The fastest year-over-year change in Total Liabilities over five years came in Q3 2021 (growth of 49.7%), and the weakest in Q1 2025 (a decline of 10.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Karyopharm Therapeutics | 11.50 Mn | -214.92 Mn | 32.35 Mn | 441.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 441.49 Mn |
| Dec 31, 2025 | 401.34 Mn |
| Sep 30, 2025 | 365.49 Mn |
| Jun 30, 2025 | 343.81 Mn |
| Mar 31, 2025 | 333.60 Mn |
| Dec 31, 2024 | 350.44 Mn |
| Sep 30, 2024 | 349.12 Mn |
| Jun 30, 2024 | 346.12 Mn |
| Mar 31, 2024 | 373.41 Mn |
| Dec 31, 2023 | 376.64 Mn |
| Sep 30, 2023 | 370.36 Mn |
| Jun 30, 2023 | 369.08 Mn |
| Mar 31, 2023 | 370.97 Mn |
| Dec 31, 2022 | 374.83 Mn |
| Sep 30, 2022 | 371.52 Mn |
| Jun 30, 2022 | 372.82 Mn |
| Mar 31, 2022 | 377.11 Mn |
| Dec 31, 2021 | 384.98 Mn |
| Sep 30, 2021 | 380.07 Mn |
| Jun 30, 2021 | 369.70 Mn |
API Access
Karyopharm Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();